Pr Laurence Bigay-Gamé
- Specialty
- Oncologist, lung expert
- Hospital
- Hôpital Larrey (Toulouse)
- Latest articles
-
- Final analysis from PECATI phase 2 trial, lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma. (Nov 13, 2026)
- Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study. (Aug 27, 2026)
- Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis. (Dec 1, 2025)
- Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study. (Nov 1, 2025)
- Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. (Sep 1, 2025)